Veldoreotide

CAT: 0804-HY-P0024Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-P0024Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Veldoreotide (DG3173) a somatostatin analogue, binds to and activate the somatostatin receptors (SSTR) 2, 4, and 5. Veldoreotide inhibits growth hormone (GH) secretion in adenomas compared withOctreotide (HY-P0036) . Veldoreotide has the potential to be used as pain modulating agent[1]
CAS Number
[252845-37-7]
Product Name Alternative
DG3173; PTR-3173
UNSPSC
12352209
Target
Somatostatin Receptor
Type
Peptides
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Cancer; Endocrinology
Assay Protocol
https://www.medchemexpress.com/veldoreotide.html
Solubility
10 mM in DMSO
Smiles
O=C(N[C@@H](C(N[C@H](C(N[C@@](C(N[C@H](C1=O)CC2=CC=CC=C2)=O)([H])[C@H](O)C)=O)CCCCN)=O)CC3=CNC4=CC=CC=C34)[C@@H](NC([C@@H](NC(CCCNC(CCCN1CC(N)=O)=O)=O)CC5=CC=CC=C5)=O)CC6=CNC7=CC=CC=C67
Molecular Formula
C60H74N12O10
Molecular Weight
1123.30
References & Citations
[1]Dasgupta P, et al. Pharmacological Characterization of Veldoreotide as a Somatostatin Receptor 4 Agonist. Life (Basel) . 2021 Oct 12;11 (10) :1075.|[2]Plöckinger U, et al. DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours. Eur J Endocrinol. 2012 Feb;166 (2) :223-34.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
Phase 2
Isoform
SSTR2; SSTR3; SSTR4

Alternative Products

CatalogName
MBS5789686Veldoreotide
MF-0120012-01Veldoreotide TFA

Popular Products